Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections

NCT00948142 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Diseases, Bacterial

Interventions

DRUG: CEM-102
DRUG: Linezolid
DRUG: CEM-102

Sponsor

Arrevus Inc.